What is the current price of nintedanib and why is it so expensive?

Nintedanib (Nintedanib) is a disease-specific drug mainly used to treat diseases such as idiopathic pulmonary fibrosis. As an original drug, its price is relatively high. At present, in China, nintedanib has passed the approval of the national medical insurance policy and has been included in the reimbursement scope of Class B medical insurance, which means that patients who meet the indications can enjoy some preferential medical insurance reimbursement.

However, it should be noted that the national medical insurance policy does not apply to all conditions. Only patients who meet specific indications can enjoy policy benefits. Patients who do not meet the indications need to purchase the drug at their own expense. The common pharmaceutical specifications of nintedanib on the market are100mg 30 pills/box and 150mg 30 pills/box, and the price is about RMB 4,000 or more. In addition to the domestic version of nintedanib, overseas versions are also on the market. For example, the Turkish and Indian versions of nintedanib have specifications of 100 mg 60 capsules and 150 mg 60 capsules per box, with a price range of 4,000 to 5,000 yuan. The specific price will be affected by exchange rate fluctuations.

In addition, there are some generic drugs available on the market. These generic drugs have similar ingredients to the original drugs and are produced by well-known manufacturers, such as BDR Pharmaceuticals in India, ASEAN in Laos and Beacon in Bangladesh. The price of these generic drugs is relatively close to the people, about more than 600 yuan per box. Of course, the price will also be affected by the exchange rate.

Generally speaking, the reason why nintedanib is more expensive is that it is an original drug with high research and development costs; on the other hand, it targets a special disease and requires long-term use, so it is an important drug choice for patients. Whether choosing original drugs or generic drugs, patients should make a choice under the guidance of a doctor and make informed decisions based on their own financial capabilities.